Abstract: The invention provides a pharmaceutical buccal, sublingual, gingival or intranasal formulation comprising tadalafil or salt thereof as active substance, a polymer, and a surfactant, and also a method for the production thereof and the use of the formulation in a medicament for treating sexual dysfunction. The average particle size of the active substance is within a range from 8 to 500 nm and the polymer is polyvinylpyrrolidone (PVP) and/or vinylpyrrolidone-vinyl acetate copolymer (KVA). The surfactant may, for example, be sodium dodecyl sulfate (SDS). The maximum serum active substance concentration occurs within just 1 hour after administration of the medicament.

Abstract: The invention relates to a complex of pure anthocyanidin and a sulfoalkyl ether ?-cyclodextrin, which complex can be formulated as an aqueous solution and as a solid, and a method for producing such a complex. Complexes according to the invention are storage-stable and can be well formulated as an aqueous solution.

Abstract: The invention relates to a complex of an anthocyanidin and a methylated ?-cyclodextrin which can be formulated as an aqueous solution and as a solid, and to a process for the preparation of such a complex. Complexes according to the invention are storage-stable and can be readily formulated in aqueous solution.

Abstract: The invention relates to a complex of pure anthocyanidin and a sulfoalkyl ether ?-cyclodextrin, which complex can be formulated as an aqueous solution and as a solid, and a method for producing such a complex. Complexes according to the invention are storage-stable and can be well formulated as an aqueous solution.

Abstract: A method for producing a flurane complex, comprising the steps of producing an aqueous solution of sulfobutylether-?-cyclodextrin (SBECD); controlling the temperature of said solution to a temperature of from 2 to 15° C.; adding the flurane to the aqueous solution; allowing the solution to react to produce the complex; and separating the complex.

Abstract: The invention relates to a composition comprising a complex of delphinidin and a sulfoalkyl ether-?-cyclodextrin for use in the treatment of malignant melanoma.

Abstract: The invention relates to a composition comprising a complex of delphinidin and a sulfoalkyl ether ?-cyclodextrin for use as an antiphlogistic and/or immunosuppressive.

Abstract: The Invention relates to an oromucosal film preparation. According to the invention, said oromucosal film preparation comprises an active-ingredient containing surface area (3) and an active-ingredient free surface area (4). Said surface area (4) which is free of active-ingredients can be used as an application aid for the safe and simple application of the film preparation.

Abstract: The invention relates to a method for producing a flurane complex, comprising the following steps: producing an aqueous solution of sulfobutylether-?-cyclodextrin (SBECD); controlling the temperature of said solution to a temperature of from 2 to 15° C.; adding the flurane to the aqueous solution; allowing the solution to react to produce the complex; and separating the complex.

Abstract: The invention relates to a complex of an anthocyanidin and a methylated ?-cyclodextrin which can be formulated as an aqueous solution and as a solid, and to a process for the preparation of such a complex. Complexes according to the invention are storage-stable and can be readily formulated in aqueous solution.

Abstract: The invention relates to a composition comprising: a complex of delphinidin and a sulfoalkyl ether-?-cyclodextrin and/or delphinidin and the salts thereof as a first component; and a tumour-necrosis factor related apoptosis-inducing ligand (TRAIL) as a second component, for use in the treatment of malignant melanoma.

Abstract: The invention relates to a composition comprising a complex of delphinidin and a sulfoalkyl ether-?-cyclodextrin for use in the treatment of malignant melanoma.

Abstract: The invention relates to a composition comprising: a complex of delphinidin and a sulfoalkyl ether-?-cyclodextrin and/or delphinidin and the salts thereof as a first component; and a tumour-necrosis factor related apoptosis-inducing ligand (TRAIL) as a second component, for use in the treatment of malignant melanoma.

Abstract: The invention relates to a composition comprising a complex of delphinidin and a sulfoalkyl ether ?-cyclodextrin for use as an antiphlogistic and/or immunosuppressive.

Abstract: The subject matter of the invention is a complex of delphinidin and a sulfoalkyl ether ?-cyclodextrin for use as a medicinal drug, in particular in the treatment of multiple myeloma.

Abstract: The invention relates to a complex made of ?-cyclodextrin and a halogenated ether, characterized by a content of the halogenated ether of at least 3 wt % of the total weight of the complex.

Abstract: The invention relates to a pharmaceutical formulation that contains a complex of a propofol salt with a cyclodextrin. The invention makes it possible to provide propofol in a formulation that can be stored and that can be administered intravenously without problems.

Abstract: The invention relates to a complex of pure anthocyanidin and a sulfoalkyl ether ?-cyclodextrin, which complex can be formulated as an aqueous solution and as a solid, and a method for producing such a complex. Complexes according to the invention are storage-stable and can be well formulated as an aqueous solution.

Abstract: The invention relates to a pharmaceutical preparation for applying a pharmaceutical agent. According to the invention, the preparation contains: a) a pharmaceutical agent which has an aromatic group or an aromatic part and the molecule of which has a maximum diameter of ?2 nm; b) a permethylated cyclodextrin having a degree of substitution of 3 methyl groups per glucopyranose unit. The permethylated cyclodextrin and the pharmaceutical agent form a complex.

Abstract: The invention relates to the use of delphinidin or salts thereof, which is aimed at bacteria selected from the group comprising antibiotic-resistant Staphylococcus aureus and antibiotic-sensitive Staphylococcus aureus and at least partially neutralizes said bacteria, and methods for treating objects with delphinidin or salts thereof.